- Home
- LESL vs FBRX Comparison
LESL vs FBRX Comparison
Compare LESL & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LESL
- FBRX
- Stock Information
- Founded
- LESL 1963
- FBRX N/A
- Country
- LESL United States
- FBRX United States
- Employees
- LESL N/A
- FBRX N/A
- Industry
- LESL Diversified Commercial Services
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- LESL Miscellaneous
- FBRX Health Care
- Exchange
- LESL Nasdaq
- FBRX Nasdaq
- Market Cap
- LESL 81.4M
- FBRX 69.7M
- IPO Year
- LESL 2020
- FBRX N/A
- Fundamental
- Price
- LESL $0.44
- FBRX $10.55
- Analyst Decision
- LESL Hold
- FBRX Strong Buy
- Analyst Count
- LESL 10
- FBRX 2
- Target Price
- LESL $1.91
- FBRX $61.00
- AVG Volume (30 Days)
- LESL 5.6M
- FBRX 187.7K
- Earning Date
- LESL 08-06-2025
- FBRX 08-13-2025
- Dividend Yield
- LESL N/A
- FBRX N/A
- EPS Growth
- LESL N/A
- FBRX N/A
- EPS
- LESL N/A
- FBRX N/A
- Revenue
- LESL $1,319,859,000.00
- FBRX N/A
- Revenue This Year
- LESL $1.64
- FBRX N/A
- Revenue Next Year
- LESL $2.74
- FBRX N/A
- P/E Ratio
- LESL N/A
- FBRX N/A
- Revenue Growth
- LESL N/A
- FBRX N/A
- 52 Week Low
- LESL $0.40
- FBRX $4.11
- 52 Week High
- LESL $4.22
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- LESL 36.49
- FBRX 44.73
- Support Level
- LESL $0.41
- FBRX $10.15
- Resistance Level
- LESL $0.52
- FBRX $13.20
- Average True Range (ATR)
- LESL 0.05
- FBRX 1.89
- MACD
- LESL 0.01
- FBRX -0.38
- Stochastic Oscillator
- LESL 28.75
- FBRX 4.72
About LESL Leslie's Inc.
Leslies Inc is a direct-to-consumer pool and spa care brand offering a comprehensive assortment of products across chemicals, equipment and parts, cleaning and maintenance equipment, and safety, recreational, and fitness-related products. The company offers its products and services for Residential Pool, Residential Spa, Professional Pool, and Commercial Pool consumers. Geographically, it operates only in the United States.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).